European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020 - Part 2.

Details

Ressource 1Download: 32964529_BIB_9775D6F86A74.pdf (282.21 [Ko])
State: Public
Version: Final published version
License: CC BY-NC 4.0
Serval ID
serval:BIB_9775D6F86A74
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020 - Part 2.
Journal
Journal of the European Academy of Dermatology and Venereology
Author(s)
Knobler R., Arenberger P., Arun A., Assaf C., Bagot M., Berlin G., Bohbot A., Calzavara-Pinton P., Child F., Cho A., French L.E., Gennery A.R., Gniadecki R., Gollnick HPM, Guenova E., Jaksch P., Jantschitsch C., Klemke C., Ludvigsson J., Papadavid E., Scarisbrick J., Schwarz T., Stadler R., Wolf P., Zic J., Zouboulis C., Zuckermann A., Greinix H.
ISSN
1468-3083 (Electronic)
ISSN-L
0926-9959
Publication state
Published
Issued date
01/2021
Peer-reviewed
Oui
Volume
35
Number
1
Pages
27-49
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
Following the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma published in 1983, this technology has received continued use and further recognition for additional earlier as well as refractory forms. After the publication of the first guidelines for this technology in the JEADV in 2014, this technology has maintained additional promise in the treatment of other severe and refractory conditions in a multidisciplinary setting. It has confirmed recognition in well-known documented conditions such as graft-vs.-host disease after allogeneic bone marrow transplantation, systemic sclerosis, solid organ transplant rejection including lung, heart and liver and to a lesser extent inflammatory bowel disease.
In order to further provide recognized expert practical guidelines for the use of this technology for all indications, the European Dermatology Forum (EDF) again proceeded to address these questions in the hands of the recognized experts within and outside the field of dermatology. This was done using the recognized and approved guidelines of EDF for this task. All authors had the opportunity to review each contribution as it was added.
These updated 2020 guidelines provide at present the most comprehensive available expert recommendations for the use of extracorporeal photopheresis based on the available published literature and expert consensus opinion. The guidelines were divided into two parts: PART I covers Cutaneous T-cell lymphoma, chronic graft-vs.-host disease and acute graft-vs.-host disease, while PART II will cover scleroderma, solid organ transplantation, Crohn's disease, use of ECP in paediatric patients, atopic dermatitis, type 1 diabetes, pemphigus, epidermolysis bullosa acquisita and erosive oral lichen planus.
Keywords
Child, Dermatology, Graft vs Host Disease, Humans, Lymphoma, T-Cell, Cutaneous/therapy, Photopheresis, Skin Neoplasms
Pubmed
Web of science
Open Access
Yes
Create date
26/09/2020 16:11
Last modification date
30/05/2021 6:35
Usage data